deutetrabenazine for the treatment of chorea associated with Huntington’s disease
This is a comprehensive review of the literature regarding the use of Deutetrabenazine in treating chorea associated with Huntington’s disease. Unfortunately, treatment has been limited for many aspects of this neurodegenerative disease. The present investigation presents the background, evidence, a...
Saved in:
Main Authors: | Harshit Gupta, Wil Perkins, Cain Stark, Sathya Kikkeri, Juyeon Kakazu, Adam D. Kaye, Alan D. Kaye |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Medical Publishing
2022-06-01
|
Series: | Health Psychology Research |
Online Access: | https://doi.org/10.52965/001c.36040 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Retrospective Analysis of Healthcare Resource Use, Treatment Patterns, and Treatment-related Events in Patients with Huntington’s Disease–associated Chorea Initiated on Tetrabenazine
by: Victor W. Sung, et al.
Published: (2018-01-01) -
Impact of Chorea on Self-care Activity, Employment, and Health-care Resource Use in Patients with Huntington’s Disease
by: Daniel O. Claassen, et al.
Published: (2021-06-01) -
Glossopharyngeal Neuralgia: Epidemiology, Risk factors, Pathophysiology, Differential diagnosis, and Treatment Options
by: Andrew Han, et al.
Published: (2022-06-01) -
pitolisant, a novel histamine-3 receptor competitive antagonist, and inverse agonist, in the treatment of excessive daytime sleepiness in adult patients with narcolepsy
by: Noeen Sarfraz, et al.
Published: (2022-05-01) -
Milnacipran for the Treatment of Fibromyalgia
by: Harshit Gupta, et al.
Published: (2021-07-01)